Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
autologous conditioned plasma + hyaluronic acid
- Development stage
- Unknown
- Lead developer
- Fundació Santiago Dexeus Font
- Modality
- Cell Therapies
- Administration
- Injection
01
Overview
Autologous conditioned plasma (ACP) combined with hyaluronic acid (HA) is a regenerative therapy being investigated for the treatment of genitourinary syndrome of menopause (GSM). ACP is a specific type of leukocyte-poor platelet-rich plasma (PRP) produced using the Arthrex ACP system, which concentrates platelets to release essential growth factors such as PDGF, TGF-β, VEGF, and EGF. These factors promote tissue repair, collagen synthesis, and angiogenesis. Hyaluronic acid serves as a bioactive scaffold and lubricant, providing immediate hydration and facilitating cell migration and signaling. When injected into the vaginal mucosa and vulva, the combination works synergistically to restore tissue elasticity, moisture, and overall mucosal health, addressing symptoms like vaginal dryness and dyspareunia. This specific combination has been studied in clinical trials sponsored by the Santiago Dexeus Font Fundacio Privada.
- Other names
- ACP + HAautologous conditioned plasma and hyaluronic acid
Beyond the preview
Go deeper on autologous conditioned plasma + hyaluronic acid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on autologous conditioned plasma + hyaluronic acid.